Sputnik V vaccine phase III first interim data analysis shows 92% efficacy Efficacy was demonstrated on the basis of a first interim analysis obtained 21 days after the first injection, of 20 confirmed…
Global SputnikV COVID-19 vaccine campaign goes live on social media The ongoing #SputnikV post-registration clinical trial in Russia involves 40,000 volunteers, with clinical trials announced in the…
